Literature DB >> 9878314

Sulfatide protects rat skin flaps against ischemia-reperfusion injury.

K Ueda1, M Nozawa, M Miyasaka, J Akamatsu, S Tajima.   

Abstract

Monoclonal antibodies to adhesion molecules have been used in many trials to prevent ischemia-reperfusion injury. Sulfatide reacts strongly with P- and L-selectin, which play an important role in the initiation of neutrophil-endothelial interactions occurring in injured or inflamed tissues. The purpose of this study was to evaluate the effect of sulfatide on ischemia-reperfusion injury of the rat skin flap. Sulfatide was administered intravenously just before elevation of the right abdominal epigastric flap. The femoral artery and vein were clamped above and below the epigastric vessels for 10 or 11 h and then the clamp was released. Administration of sulfatide augmented significantly the flap area surviving in the 10-h ischemic model (7.18 +/- 0.47 cm2 versus control 5.15 +/- 0.39 cm2. P = 0.01). In the 11-h ischemic model the area was 4.59 +/- 0. 36 cm2 versus control 1.73 +/- 0.31 cm2 (P = 0.001). The ATP levels in the flap gradually increased after release of the clamp in the rat administered sulfatide, and the increase was significant at 48 h (P = 0.006). Histological examination 48 h after surgery showed greater leukocyte invasion into the control flap than into the flap of the rat administered sulfatide. Myeloperoxidase activity was significantly reduced 48 h after reperfusion in the 11-h ischemic model. This study indicates that sulfatide has a significant protective effect against ischemia and reperfusion in rat epigastric flaps. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878314     DOI: 10.1006/jsre.1998.5443

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Sulphatides trigger polymorphonuclear granulocyte spreading on collagen-coated surfaces and inhibit subsequent activation of 5-lipoxygenase.

Authors:  G F Sud'ina; T G Brock; M A Pushkareva; S I Galkina; D V Turutin; M Peters-Golden; V Ullrich
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

2.  Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.

Authors:  Jeff S Isenberg; Fuminori Hyodo; Ken-Ichiro Matsumoto; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; Periannan Kuppusamy; David A Wink; Murali C Krishna; David D Roberts
Journal:  Blood       Date:  2006-11-02       Impact factor: 22.113

3.  Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.

Authors:  Jeff S Isenberg; Loretta K Pappan; Martin J Romeo; Mones Abu-Asab; Maria Tsokos; David A Wink; William A Frazier; David D Roberts
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

4.  Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.

Authors:  Jeff S Isenberg; Sruti Shiva; Mark Gladwin
Journal:  Nitric Oxide       Date:  2009-05-27       Impact factor: 4.427

5.  Polymorphonuclear leukocyte apoptosis is accelerated by sulfatides or sulfatides-treated Salmonella Typhimurium bacteria.

Authors:  Zoryana V Grishina; Galina M Viryasova; Yulia M Romanova; Galina F Sud'ina
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

6.  Improvement of tissue survival of skin flaps by 5α-reductase inhibitors: possible involvement of nitric oxide and inducible nitric oxide synthase.

Authors:  Ali Asghar Karimi; Marjan Ajami; Yasin Asadi; Nahid Aboutaleb; Fazel Gorjipour; Roya Malekloo; Hamidreza Pazoki-Toroudi
Journal:  Iran Biomed J       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.